
    
      The study is being conducted from Jan 2021 to Dec 2025 in 20 neurosurgical units. It
      comprises 2 parts: the registry part and the trial part. The registry part is a multicentric,
      real-world registry. The trial part is designed as a multicenter, prospective, randomized
      clinical trial. The two parts include the intervention group and the medical group. The
      safety and efficacy of surgical treatment in severe primary pontine hemorrhage will be
      validated.
    
  